July 14, 2008 - LUMEDX Corp. today introduced CardioPACS 5.0, the latest version of its cardiology PACS software.

The multimodality, Web-enabled and vendor-neutral CardioPACS 5.0 offers new and better ways to manage images and data with a fully integrated suite of applications, modules.

July 14, 2008 - Diagnosis decision support software maker Isabel Healthcare last week said it added two new subscribers to its system - Luther Midelfort-Mayo Health System in Eau Claire, WI, and Children’s Hospitals and Clinics of Minnesota in Minneapolis and St. Paul, MN.

With the addition of Children’s Hospitals and Clinics of Minnesota, Isabel is now used for diagnosis decision support at four (or 10 percent) of the 43 hospitals which form the Child Health Corp. of America, a purchasing and performance improvement network of leading, independent children’s hospitals.

July 14, 2008 - Micrus Endovascular Corp. today said the Pharos Vitesse Intracranial Stent Study for Ischemic Therapy (VISSIT) clinical trial application has been conditionally approved by the FDA.

LUMEDX Corp. offers the CardioPACS 5.0, the latest version of its cardiology PACS software.

The multi-modality, Web-enabled and vendor-neutral CardioPACS 5.0 offers new and better ways to manage images and data with a fully integrated suite of applications, modules.

July 11, 2008 - Bioheart Inc. this week said it secured worldwide, nonexclusive distribution rights to the Bioheart 3370 Heart Failure Monitor, an interactive and simple-to-use at-home device designed to better monitor patients outside hospitals who are suffering from heart failure.

The device, manufactured by RTX Healthcare A/S (Denmark), has FDA 510(k) market clearance and CE Mark in Europe. The company is planning to begin immediate commercial distribution.

July 11, 2008 - Micrus Endovascular Corp. said this week it received approval from the Ministry of Health, Labour and Welfare (MHLW) to market in Japan the Cerecyte microcoil product line, including the MicruSphere, Presidio, HeliPaq and UltiPaq Cerecyte embolic coils, for the endovascular treatment of cerebral aneurysms.

July 11, 2008 - A new study that found wireless systems that track hospital medical equipment can cause potentially hazardous incidents involving lifesaving devices may have caused needless alarmed, says a biomedical engineering technology professor at Indiana University-Purdue University Indianapolis (IUPUI).

July 11, 2008 - St. Jude Medical Inc. today received European CE Mark approval and began its European launch of its line of HydroSteer Hydrophilic-Coated Nitinol Guidewires.

The HydroSteer line of guidewires features a lubricious hydrophilic coating, which becomes slippery when wet, thereby reducing friction and enabling physicians to more easily maneuver the wires through the patient’s vessels. The HydroSteer line includes a wide variety of sizes, lengths and configurations.

July 11, 2008 - AngioScore Inc. today announced the launch of new longer and larger AngioSculpt PTA Scoring Balloon Catheters for the treatment of peripheral artery disease (PAD).

The new devices have FDA 510(k) clearance to market for the dilatation of lesions in the iliac, femoral, ilio-femoral, popliteal, and infra popliteal arteries, and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae. The PTA catheter is not labeled for use in the coronary or neuro-vasculature.

AngioScore Inc. has introduced longer and larger AngioSculpt PTA Scoring Balloon Catheters for the treatment of peripheral artery disease (PAD).

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now